Study of Safety, Pharmacokinetics, and Antitumor Activity of BGB-3245 in Participants With Advanced or Refractory Tumors
Clinical trial NCT04249843 · TERMINATED
Trial details
- NCT number
- NCT04249843
- Sponsor
- MapKure, LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-17
- Primary completion
- 2025-08-04
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.